DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pv4pkh/20162020) has announced the addition of the "2016-2020 Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse" report to their offering.
This comprehensive seven-country report contains 1,115 pages and 450 tables. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.
The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, and physician offices, including controls, calibrators and consumables.
Contains 1,115 pages and 450 tables
- Abbott Laboratories
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Instrumentation Laboratory
- Kyowa Medex
For more information visit http://www.researchandmarkets.com/research/pv4pkh/20162020